Cite
HARVARD Citation
Susarla, S. et al. (2019). Immunogenicity and safety of a liquid Pentavalent (DTwP-Hb-Hib) combination vaccine manufactured by Human Biologicals Institute in 6–8 weeks old healthy infants: A phase III, randomized, single blind, non-inferiority study. Vaccine. 37 (36), pp. 5452-5459. [Online].